XPH:NYE-SPDR® S&P Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 43.88

Change

0.00 (0.00)%

Market Cap

N/A

Volume

9.51K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing XPH

INAV 10.31 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -47.28% 29% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -47.28% 29% F 10% F
Trailing 12 Months  
Capital Gain -44.81% 29% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.81% 29% F 9% A-
Trailing 5 Years  
Capital Gain -38.35% 33% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.35% 33% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain 0.14% N/A N/A 37% F
Dividend Return 0.84% N/A N/A 29% F
Total Return 0.69% N/A N/A 17% F
Risk Return Profile  
Volatility (Standard Deviation) 15.30% N/A N/A 63% D
Risk Adjusted Return 5.47% N/A N/A 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike